Prevention and treatment of fungal infection after solid organ transplantation

Deng Feiwen

doi:10.3969/j.issn.1674-7445.2022.04.006

Volume 13 Issue 4

Jul. 2022

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2022 > 13(4): 448-454

Deng Feiwen. Prevention and treatment of fungal infection after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 448-454. doi: 10.3969/j.issn.1674-7445.2022.04.006

Citation:

Deng Feiwen. Prevention and treatment of fungal infection after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 448-454. doi: 10.3969/j.issn.1674-7445.2022.04.006

Citation:

Deng Feiwen. Prevention and treatment of fungal infection after solid organ transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 448-454. doi: 10.3969/j.issn.1674-7445.2022.04.006

PDF( 7402 KB)

Prevention and treatment of fungal infection after solid organ transplantation

doi: 10.3969/j.issn.1674-7445.2022.04.006

Deng Feiwen^,

Department of Hepatopancreas Surgery, the First People's Hospital of Foshan, Foshan 528000, China

More Information

Corresponding author: Deng Feiwen, Email: dengfeiwen2012@163.com
Received Date: 2022-03-21
Available Online: 2022-07-14
Publish Date: 2022-07-15

Abstract

Abstract

Over nearly 70-year development, organ transplantation has become an effective treatment for multiple end-stage diseases. However, postoperative administration of immunosuppressants should be given for the recipients, which leads to low immune function and high incidence rate of infection, including viral, bacterial and fungal infections. Among them, the occurrence of fungal infection is hidden, and it is difficult to deliver prompt diagnosis. Candida, Aspergillus, Cryptococcus and Pneumocystis infection are common fungal infections in solid organ transplantation. High-risk factors of fungal infection after solid organ transplantation should be identified and prevented in advance, and prompt diagnosis and treatment should be carried out by combining the results of (1, 3)-β-D-glucan assay (fungal G-test), imaging examination and related body fluid culture. These interventions are of clinical significance to reduce the incidence of fungal infection and fatality after solid organ transplantation. In this article, common fungal infections after organ transplantation were reviewed, aiming to provide reference for the prevention and treatment of fungal infections after organ transplantation.
- Organ transplantation,
- Fungal infection,
- Candida,
- Aspergillus,
- Cryptococcus,
- Pneumocystis,
- Echinocandin,
- Amphotericin B

FullText(HTML)

References(34)

References

[1]	MURRAY JE. The 50th anniversary of the first successful human organ transplant[J]. Rev Invest Clin, 2005, 57(2): 118-119.
[2]	RAKELA J, FUNG JJ. Thomas E. Starzl, M.D., Ph. D. (1926-2017)[J]. Hepatology, 2017, 66(1): 306-308. DOI: 10.1002/hep.29214.
[3]	NANAYAKKARA DD, SCHAENMAN J. Screening of donors and recipients for infections prior to solid organ transplantation[J]. Curr Opin Organ Transplant, 2019, 24(4): 456-464. DOI: 10.1097/MOT.0000000000000671.
[4]	魏绪霞, 易慧敏. 器官移植供者来源性感染防治的研究进展[J]. 器官移植, 2020, 11(1): 115-120. DOI: 10.3969/j.issn.1674-7445.2020.01.019. WEI XX, YI HM. Research progress on prevention and treatment of donor-derived infection in organ transplantation[J]. Organ Transplant, 2020, 11(1): 115-120. DOI: 10.3969/j.issn.1674-7445.2020.01.019.
[5]	张坚磊. 实体器官移植受者侵袭性真菌感染的实验室诊断[J/CD]. 实用器官移植电子杂志, 2018, 6(3): 234-239. DOI: 10.3969/j.issn.2095-5332.2018.03.020. ZHANG JL. Laboratory diagnosis of invasive fungal infection in solid organ transplant recipients[J/CD]. Pract J Organ Transplant (Electr Vers), 2018, 6(3): 234-239. DOI: 10.3969/j.issn.2095-5332.2018.03.020.
[6]	NEOFYTOS D, GARCIA-VIDAL C, LAMOTH F, et al. Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response[J]. BMC Infect Dis, 2021, 21(1): 296. DOI: 10.1186/s12879-021-05958-3.
[7]	PAPPAS PG, ALEXANDER BD, ANDES DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Clin Infect Dis, 2010, 50(8): 1101-1111. DOI: 10.1086/651262.
[8]	ANDES DR, SAFDAR N, BADDLEY JW, et al. The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Transpl Infect Dis, 2016, 18(6): 921-931. DOI: 10.1111/tid.12613.
[9]	刘琳, 王慧, 刘宁宁. 侵袭性念珠菌感染在免疫力低下人群中的流行病学和治疗进展[J]. 上海交通大学学报(医学版), 2021, 41(4): 525-529. DOI: 10.3969/j.issn.1674-8115.2021.04.018. LIU L, WANG H, LIU NN. Advances in epidemiology and treatment of invasive Candida infection in the immunocompromised population[J]. J Shanghai Jiaotong Univ (Med Sci), 2021, 41(4): 525-529. DOI: 10.3969/j.issn.1674-8115.2021.04.018.
[10]	ASLAM S, ROTSTEIN C, AST Infectious Disease Community of Practice. Candida infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13623. DOI: 10.1111/ctr.13623.
[11]	CLANCY CJ, NGUYEN MH. Diagnosing invasive candidiasis[J]. J Clin Microbiol, 2018, 56(5): e01909-e01917. DOI: 10.1128/JCM.01909-17.
[12]	KABIR V, MAERTENS J, KUYPERS D. Fungal infections in solid organ transplantation: an update on diagnosis and treatment[J]. Transplant Rev (Orlando), 2019, 33(2): 77-86. DOI: 10.1016/j.trre.2018.12.001.
[13]	HOU TY, WANG SH, LIANG SX, et al. The screening performance of serum 1, 3-Beta-D-glucan in patients with invasive fungal diseases: a Meta-analysis of prospective cohort studies. [J] PLoS One, 2015, 10(7): e0131602. DOI: 10.1371/journal.pone.0131602.
[14]	LIU M, ZHU Z, SUN L. Risk factors of invasive fungal infection in recipients after liver transplantation: a systematic review and Meta-analysis[J]. Front Med (Lausanne), 2021, 8: 687028. DOI: 10.3389/fmed.2021.687028.
[15]	PHOOMPOUNG P, HERRERA S, PÉREZ CORTÉS VILLALOBOS A, et al. Risk factors of invasive fungal infections in liver transplant recipients: a systematic review and Meta-analysis[J]. Am J Transplant, 2022, 22(4): 1213-1229. DOI: 10.1111/ajt.16935.
[16]	SILVA JT, SAN-JUAN R, FERNÁNDEZ-CAAMAÑO B, et al. Infectious complications following small bowel transplantation[J]. Am J Transplant, 2016, 16(3): 951-959. DOI: 10.1111/ajt.13535.
[17]	HUSAIN S, CAMARGO JF. Invasive aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13544. DOI: 10.1111/ctr.13544.
[18]	JU C, LIAN Q, XU X, et al. Epidemiology and prognosis of invasive fungal disease in Chinese lung transplant recipients[J]. Front Med (Lausanne), 2021, 8: 718747. DOI: 10.3389/fmed.2021.718747.
[19]	中华医学会器官移植学分会. 器官移植受者侵袭性真菌病临床诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002 Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for clinical diagnosis and treatment for invasive fungal disease in organ transplant recipients (2019 edition)[J]. Organ Transplant, 2019, 10(3): 227-236. DOI: 10.3969/j.issn.1674-7445.2019.03.002
[20]	NEOFYTOS D, CHATZIS O, NASIOUDIS D, et al. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study[J]. Transpl Infect Dis, 2018, 20(4): e12898. DOI: 10.1111/tid.12898.
[21]	HUSAIN S, SILVEIRA FP, AZIE N, et al. Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance^® registry analysis[J]. Med Mycol, 2017, 55(3): 269-277. DOI: 10.1093/mmy/myw086.
[22]	PÉREZ-JACOISTE ASÍN MA, LÓPEZ-MEDRANO F, FERNÁNDEZ-RUIZ M, et al. Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and Meta-analysis[J]. Am J Transplant, 2021, 21(2): 703-716. DOI: 10.1111/ajt.16248.
[23]	CHULEERARUX N, THONGKAM A, MANOTHUMMETHA K, et al. Does post-transplant cytomegalovirus increase the risk of invasive aspergillosis in solid organ transplant recipients? a systematic review and Meta-analysis[J]. J Fungi (Basel), 2021, 7(5): 327. DOI: 10.3390/jof7050327.
[24]	PATTERSON TF, THOMPSON GR 3RD, DENNING DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 63(4): e1-e60. DOI: 10.1093/cid/ciw326.
[25]	ULLMANN AJ, AGUADO JM, ARIKAN-AKDAGLI S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline[J]. Clin Microbiol Infect, 2018, 24(Suppl 1): e1-e38. DOI: 10.1016/j.cmi.2018.01.002.
[26]	SAMANTA P, CLANCY CJ, NGUYEN MH. Fungal infections in lung transplantation[J]. J Thorac Dis, 2021, 13(11): 6695-6707. DOI: 10.21037/jtd-2021-26.
[27]	GEORGE IA, SANTOS CAQ, OLSEN MA, et al. Epidemiology of cryptococcosis and cryptococcal meningitis in a large retrospective cohort of patients after solid organ transplantation[J]. Open Forum Infect Dis, 2017, 4(1): ofx004. DOI: 10.1093/ofid/ofx004.
[28]	BADDLEY JW, FORREST GN, AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13543. DOI: 10.1111/ctr.13543.
[29]	PERFECT JR, BICANIC T. Cryptococcosis diagnosis and treatment: what do we know now[J]. Fungal Genet Biol, 2015, 78: 49-54. DOI: 10.1016/j.fgb.2014.10.003.
[30]	WALD-DICKLER N, SHE R, BLODGET E. Cryptococcal disease in the solid organ transplant setting: review of clinical aspects with a discussion of asymptomatic cryptococcal antigenemia[J]. Curr Opin Organ Transplant, 2017, 22(4): 307-313. DOI: 10.1097/MOT.0000000000000426.
[31]	FISHMAN JA, GANS H, AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13587. DOI: 10.1111/ctr.13587.
[32]	PERMPALUNG N, KITTIPIBUL V, MEKRAKSAKIT P, et al. A comprehensive evaluation of risk factors for pneumocystis jirovecii pneumonia in adult solid organ transplant recipients: a systematic review and Meta-analysis[J]. Transplantation, 2021, 105(10): 2291-2306. DOI: 10.1097/TP.0000000000003576.
[33]	BRAKEMEIER S, PFAU A, ZUKUNFT B, et al. Prophylaxis and treatment of pneumocystis jirovecii pneumonia after solid organ transplantation[J]. Pharmacol Res, 2018, 134: 61-67. DOI: 10.1016/j.phrs.2018.06.010.
[34]	MILLER R, ASSI M, AST Infectious Diseases Community of Practice. Endemic fungal infections in solid organ transplant recipients-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13553. DOI: 10.1111/ctr.13553.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (374) PDF downloads(150)

Prevention and treatment of fungal infection after solid organ transplantation

doi: 10.3969/j.issn.1674-7445.2022.04.006

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Prevention and treatment of fungal infection after solid organ transplantation

doi: 10.3969/j.issn.1674-7445.2022.04.006

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content